Document is current

Any future updates will be listed below

The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo

Crossref DOI link: https://doi.org/10.1007/s12275-022-1661-7

Published Online: 2022-04-18

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark